BACKGROUND: Since most patients with hepatitis C virus (HCV) infection now receive treatment irrespective of liver disease severity, special attention to patient quality of life (QoL), including psycho-social aspects, is required. No QoL questionnaire is specific for patients with HCV. AIMS: To develop and validate a short Italian questionnaire (HepaDisk) assessing the QoL of patients affected by HCV with intuitive graphic results that is understandable by patients and physicians. METHODS: A questionnaire, drafted by a steering committee, underwent a Delphi survey. A multicenter, observational study was conducted to validate the developed HepaDisk versus other tools (CLDQ-I, SF-36, WPAI:HCV), and to evaluate its correlation with disease severity in Italian patients with HCV. RESULTS: The 10-item questionnaire was validated in 214 patients. HepaDisk showed a high correlation with CLDQ overall score and WPAI:HCV activity impairment (Spearman's rank correlation: 0.651 and 0.595, respectively) and a lower correlation with SF-36. Strong internal consistency (Cronbach coefficient: 0.912), good test-retest reliability (Pearson's correlation coefficient: 0.789; 95% CI, 0.714-0.865), and responsiveness to changes among improved patients were demonstrated. CONCLUSION: HepaDisk is a reliable and user-friendly tool that can monitor disease impact on patient QoL over time, providing a visual representation easily understandable by both patients and physicians.
|Titolo:||HepaDisk – A new quality of life questionnaire for HCV patients|
|Data di pubblicazione:||23-dic-2018|
|Citazione:||Fagiuoli, S., Caporaso, N., Morisco, F., Buelli, F., Gualberti, G., Saragaglia, V., et al. (2018). HepaDisk – A new quality of life questionnaire for HCV patients. DIGESTIVE AND LIVER DISEASE.|
|Appare nelle tipologie:||1.01 Articolo in rivista|
File in questo prodotto:
|HepaDisk – A new quality of life questionnaire for HCV patients Dig Liv Dis 2018.pdf||N/A||Open Access Visualizza/Apri|